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Predictive Significance of Blood Pressure Values for the Incidence of Cardiovascular Events in Chronic Hemodialysis Patients
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Introduction
Because the incidence of end-stage renal disease (ESRD) is increasing in Japan as well as in Western countries, the improvement of prognoses for dialysis patients is becoming an important issue. Patients undergoing dialysis therapy are at more than 10 times higher risk for developing cardiovascular diseases than the general population; these cardiovascular complications often limit the life expectancy of dialysis patients (1) . Therefore, the intensive management of cardiovascular risk factors is necessary for the prevention of cardiovascular diseases and the improvement of prognoses in dialysis patients. Among the cardiovascular risk factors, hypertension has a pivotal impact on the development of cardiovascular diseases such as stroke, coronary heart disease and heart failure in various populations. A large-scale meta-analysis of the middle-and old-aged general population showed a linear relationship between blood pressure and mortality due to cardiovascular diseases that can be extended to the normotensive population (2) . However, such a linear relationship was not necessarily observed in earlier studies investigating the influence of blood pressure on mortality and cardiovascular morbidity in hemodialysis patients (3) . Moreover, it has been reported that low diastolic blood pressure (DBP) was instead associated with poor life prognoses for hemodialysis patients that were followed for 5 years (4) . In clinical practice, systolic blood pressure (SBP) and DBP are generally evaluated for the management of hypertension. In addition, several clinical studies have indicated the significance of pulse pressure (PP) as an independent predictor of future cardiovascular events in patients with hypertension (5) .
In this prospective study, we followed a cohort of hemodialysis patients and assessed the relationship between blood pressure values and the incidence of cardiovascular diseases and survival.
Methods
We enrolled a total of 553 patients with ESRD who were undergoing stable maintenance hemodialysis as an outpatient for more than three months on January 1, 1998 at the hemodialysis unit of Dokkyo Medical University Hospital (Tochigi, Japan) and eight nearby hemodialysis hospitals and clinics. Patients with uncured cancer were excluded; however, all eligible subjects participated in the study. Baseline data were collected, including medical history, physical examination, habits of cigarette smoking and alcohol consumption, cardiothoracic ratio on chest roentgenogram and electrocardiographic findings. Blood pressure was measured before each dialysis session on the arm without blood access using a sphygmomanometer with the patient in a supine position after having rested for at least 10 min. The average blood pressure values over 2 weeks were used for the evaluation (6, 7) . PP was calculated by subtracting the DBP from the SBP. Mean blood pressure (MBP) was defined as (SBP + 2 × DBP)/ 3. Routine hematological and chemical analyses were performed using blood taken before the dialysis session.
After their registration in January 1998, the patients were followed up until January 2003. The primary endpoint was the occurrence of cardiovascular events that required hospitalization or caused death. Cardiovascular events were classified into the following categories: stroke, coronary heart disease, heart failure, arrhythmia (including sudden death) and other vascular diseases. Cerebral stroke was diagnosed by means of neurological signs and symptoms together with computed tomography, if available. Coronary heart disease was diagnosed by means of chest symptoms and electrocardiogram. Elevation of serum cardiac enzyme was ascertained in diagnosing myocardial infarction. Clinical symptoms and chest roentgenogram were evaluated for the diagnosis of heart failure. Arrhythmia was diagnosed based on a standard 12-lead electrocardiogram. Other vascular diseases include arteriosclerotic obliteration, dissecting aneurysm of the aorta and pulmonary embolism. Stenosis or occlusion of the arteriovenous fistula used for blood access was not included in the cardiovascular events category. The secondary endpoint in this study was death due to any cause. The cause of each death was reviewed by a panel of four physicians. In the review process, all available information was collected, including medical records and interviews with the attending medical staff and family members that witnessed the event. Mean±SD.
The study protocol was in accordance with the recommendations of the World Medical Association for biomedical research involving human subjects (Somerset West version, 1996) and was approved by the institutional review board. Informed consent was obtained from all subjects.
Values are expressed as means±SD. Univariate and multivariate Cox proportional hazards analyses were performed to evaluate the influence of variables on the incidence of cardiovascular events and death. The χ 2 test and the Steel test were used for the analyses of categorical data. A p value less than 0.05 was considered to indicate statistical significance. Table 1 lists physical and background characteristics of the study subjects. The leading cause of renal failure was chronic glomerulonephritis followed by diabetic nephropathy. These statistics are consistent with the overall major causes of renal failure in Japan in 1998. Of the 553 patients, 185 had a past or present history of such cardiovascular diseases as cerebrovascular disease (n= 44), coronary heart disease (n= 58), valvular heart disease (n= 31), arrhythmia (n= 51), heart failure (n= 44) and peripheral vascular disease (n= 19). Thirty-three patients had two or more cardiovascular diseases. Habitual drinkers and smokers included 22.1% and 34.2% of the patients, respectively. Only 36 (6.5%) had body mass indices greater than 25 kg/m 2 . With regard to blood pressure values, the average SBP measured before each dialysis session was in the hypertensive range. As many as 441 patients (79.7%) were taking antihypertensive drugs; calcium channel blockers were the most frequently used drugs. One hundred and sixtyseven patients were taking one antihypertensive drug, 142 patients were taking two drugs and 132 patients were taking three or more drugs. Laboratory findings were shown in Table  2 . In addition to renal anemia, increases in serum urea nitrogen, creatinine, potassium, inorganic phosphorus and β2-microglobulin were naturally observed in the chronic hemodialysis patients enrolled in this study.
Results
During the 5 years, three patients successfully underwent renal transplantation at 33, 37 and 40 months, and their follow-ups were discontinued thereafter. Except for these three patients, all other patients were followed up until their death or when the 5 years of the study had passed. As indicated in Table 3 , fatal and nonfatal cardiovascular events occurred in 205 patients. Table 4 shows the relationship between the background characteristics (including blood pressure values) and the incidence of these cardiovascular events as evaluated by univariate Cox proportional hazard analysis. Among the baseline characteristics of the patients, age, diabetes, preexistence of cardiovascular diseases, PP, cardiothoracic ratio on chest roentgenogram and left ventricular hypertrophy on electrocardiogram were the most highly significant factors related to the risk of cardiovascular events. SBP, in addition to PP, was significantly related to the incidence of cardiovascular events in the univariate Cox proportional hazards analysis. Increases in SBP and PP by 10 mmHg correspond to a 10.4% and 21.9% higher risk of developing cardiovascular diseases, respectively. Figure 1 presents the incidence of total cardiovascular events in the study subjects divided into quintiles according to blood pressure values. The incidence of cardiovascular events increased with increasing SBP and PP. Such a linear relation was not apparent for MBP. On the other hand, the relationship between cardiovascular event incidence and DBP was a Ushaped curve; the incidence of cardiovascular events in the lowest DBP quintile was significantly higher than that of the middle quintile (p= 0.036). Table 5 presents the relationship between blood pressure values and the risk of each cardiovascular disease category, as analyzed by the univariate Cox proportional hazards model. PP showed a significant association with the risk of stroke, coronary heart disease, heart failure and other vascular diseases, while only the incidence of stroke was significantly associated with SBP. Including 85 patients who had developed fatal cardiovascular events, a total of 173 patients died during the 5 years. Table 6 shows the causes of these 173 deaths. Nearly half of them (49.4%) were due to cardiovascular diseases. Baseline characteristics such as male gender (hazard ratio of 1.426, p= 0.033), age (hazard ratio of 1.068 for 1 year increase, p< 0.001), diabetes (hazard ratio of 2.252, p< 0.001), preexistence of cardiovascular diseases (hazard ratio of 1.731, p< 0.001), habitual smoking (hazard ratio of 1.014, p= 0.045), cardiothoracic ratio on chest roentgenogram (hazard ratio of 1.076 for 1% increase, p< 0.001) and left ventricular hypertrophy on electrocardiogram (1.866, p< 0.001) were significantly associated with the risk of death in the univariate Cox proportional hazards analysis. As for blood pressure values, only PP had a significant association with the incidence of death in the univariate Cox proportional hazards analysis (Table 7 ). In addition to PP, SBP also showed a significant relationship with the incidence of death due to cardiovascular diseases, however, no blood pressure values were significantly associated with the incidence of death by noncardiovascular causes. The 10 mmHg increase in PP corresponded to 16 .1% higher risk of death in the study subjects on chronic hemodialysis.
Next, variables showing a significant association with cardiovascular events in univariate regression analyses were Table 8 remained as independent predictors of cardiovascular events. As might be anticipated, older age, diabetes, preexistence of cardiovascular diseases and electrocardiographic left ventricular hypertrophy were selected as independent risk factors. In addition, PP remained an independent variable relating to the occurrence of cardiovascular events, even after correcting for the influence of other variables.
Discussion
Effects of blood pressure on the artery consist of two components: a steady component reflected by MBP and a pulsatile component reflected by PP. While the steady component is determined by the balance between cardiac output and peripheral vascular resistance, the pulsatile component depends on left ventricular stroke volume, arterial elasticity and wave reflection. After aging 50 years, DBP tends to decrease while SBP continues to increase, resulting in the increase of PP with advancing age (8) . This increase in PP with age in later life is mainly brought about by stiffening of large arteries as a result of arteriosclerosis. It has been shown that increased PP is associated with the risk of developing cardiovascular diseases not only in hypertensive patients but also in normotensive subjects (9) . It has also been shown that the progression of atherosclerosis and arterial calcification is accelerated in hemodialysis patients, resulting in increased arterial stiffness and increased PP (10) (11) (12) (13) . In addition, the existence of arteriovenous fistula for blood access increases left ventricular ejection and reduces total vascular resistance, resulting in the increase of PP in hemodialysis patients. Therefore, it is intriguing to obtain particular information about the implications of PP for cardiovascular risk in hemodialysis patients.
In the present study, PP better predicted the incidence of cardiovascular events than other blood pressure values in chronic hemodialysis patients. PP was significantly related to the risk of stroke, coronary heart disease, heart failure and peripheral vascular disease, while only the incidence of stroke was significantly related to SBP. Other blood pressure values did not significantly associate with the risk of developing cardiovascular events. PP was the only blood pressure value that was significantly associated with the incidence of death in hemodialysis patients. The results of present study also indicated a U-shaped relationship between DBP and cardiovascular events. Although the number of events did not afford enough statistical power, the higher incidence of coronary artery disease and arrhythmia seems to contribute to the increased cardiovascular events in the lower quintiles. Because coronary blood flow largely depends on the diastolic phase, it is speculated that low DBP causes myocardial ischemia and thereby induces arrhythmia as well (14) . Considering that PP is increased by stiffening of the arteries, it seems reasonable that increased PP is associated with the increased risk of cardiovascular diseases caused by the progression of arteriosclerosis. Arteriosclerosis of the cerebral arteries contributes to the onset of stroke and arteriosclerosis of the coronary arteries naturally causes ischemic heart disease. Several earlier studies have analyzed the relationship between PP and mortality and the risk of cardiovascular events in patients with ESRD. Klassen et al. (15) have reported the association between PP and mortality in hemodialysis patients, and Tozawa et al. (16) have reported the association of PP and the incidence of stroke and myocardial infarction in patients on chronic hemodialysis. In addition, the present study indicated that PP is a significant predictor of heart failure and peripheral vascular diseases. It would be expected that coronary artery disease and left ventricular hypertrophy, which progress along with arteriosclerosis, impair left ventricular function and facilitate the development of heart failure (17, 18) . Peripheral vascular diseases such as arteriosclerotic obliteration are obviously related to the development of arteriosclerosis, which causes arterial stiffening and an increase in PP. Compared with these triggers, the cause of arrhythmia may not have a direct relationship with stiffening of the arteries, and PP did not show a significant association with the occurrence of arrhythmia and sudden death in the present study.
It is known that arteriosclerosis and stiffening of arteries progress with increasing age and with the existence of diabetes. Because aging and diabetes are certain risk factors for death and cardiovascular diseases, the relationship between PP and the incidence of death and cardiovascular events observed in this study may be mediated by influences of aging and diabetes. However, the relationship between PP and the cardiovascular event incidence was still significant, even when analyzed in the multivariate model incorporating other factors such as age and diabetes as covariates. Therefore, increasing PP is thought to be associated with an increasing risk of developing cardiovascular diseases in chronic hemodialysis patients.
It has been reported that the indices of arteriosclerosis such as pulse wave velocity, ultrasonographic measurement of carotid intima media thickness and radiological evaluation of aortic calcification were predictive of mortality or cardiovascular morbidity (19) (20) (21) . Compared with these parameters of arteriosclerosis, measurements of blood pressure and calculation of PP is feasible in clinical practice. Regarding the blood pressure evaluation, 24-h blood pressure monitoring has been shown to correlate with cardiovascular organ injuries better than clinical measurements (22) . In the present study, we used the averaged values of pre-dialysis blood pressure measurements over a 2 week period. It has been reported that such averaged values of repeated blood pressure measurements showed a close correlation with 24-h blood pressure and left ventricular mass in hemodialysis patients (6, 7) .
Because hypertension is prevalent in patients with ESRD, intensive antihypertensive treatment is required for the control of blood pressure in hemodialysis patients. Among the classes of antihypertensive drugs, calcium channel blockers are most frequently used in hemodialysis patients. Calcium channel blockers lower SBP by directly dilating the arteries, but may not be very effective at reducing PP because DBP is lowered as well. On the other hand, inhibitors of the reninangiotensin system, such as angiotensin II receptor blockers, have been shown to reduce PP (23) . It is also speculated that β-blockers may be effective at reducing PP by reducing left ventricular ejection, another determinant of PP. In this context, angiotensin converting enzyme (ACE) inhibitors and β- blockers have been reported to improve survival of hemodialysis patients, and this may be related to the reduction in PP (24, 25) . Further prospective investigations are needed to delineate effective antihypertensive therapy in reducing PP and improving the cardiovascular risk and prognosis of patients with ESRD.
Considering that hemodialysis patients are at markedly high risk for developing cardiovascular diseases, adequate blood pressure control is strongly desired for the reduction of cardiovascular events and mortality. The results of the present study suggest that care should be taken to reduce not only SBP, but also PP in the antihypertensive treatment of chronic hemodialysis patients in order to improve their prognosis.
